Publication | Closed Access

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

Oncology5-Fluorouracil RegimenMedicineMetastatic Colorectal CancerColorectal CancerBimonthly LeucovorinCancer TreatmentPharmacologyRadiation Oncology